Evidence map›Paper›PMID 22821995›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2012

The severity of shock is associated with impaired rates of net alveolar fluid clearance in clinical acute lung injury.

Yosaf F Zeyed, Julie A Bastarache, Michael A Matthay, Lorraine B Ware

Abstract readMulticenter Study
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. The ex vivo perfused human lung is resistant to injury by high-doseAmerican journal of physiology. Lung cellular and molecular physiology · 2020
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Profiling of ARDS pulmonary edema fluid identifies a metabolically distinct subset.American journal of physiology. Lung cellular and molecular physiology · 2017
    Article
  11. Review
  12. Article
  13. Novel regulators of endothelial barrier function.American journal of physiology. Lung cellular and molecular physiology · 2014
    Review
  14. Resolution of pulmonary edema. Thirty years of progress.American journal of respiratory and critical care medicine · 2014
    Article
  15. Article
  16. Article
  17. Chloroquine relieves acute lung injury in rats with acute hemorrhagic necrotizing pancreatitis.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2013
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yosaf F ZeyedDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Julie A Bastarache
Michael A Matthay
Lorraine B Ware
Pulmonary and Allergy Associates · USUniversity of California, San Francisco · US

Funding

Resolution of Clinical Lung InjuryR37HL051856 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHAY, MICHAEL A. · 2006 to 2015
$3.9M
RESOLUTION OF CLINICAL LUNG INJURYR01HL051856 · NHLBI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MATTHAY, MICHAEL A. · 1996 to 2005
$1.7M
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung InjuryK24HL103836 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WARE, LORRAINE B · 2010 to 2020
$1.6M
Tissue Factor Mediated Fibrin Deposition in Acute Lung InjuryK08HL090785 · NHLBI · VANDERBILT UNIVERSITY · PI BASTARACHE, JULIE ANNE · 2009 to 2013
$629k
NHLBI NIH HHS HL090785NHLBI NIH HHS HL103836NHLBI NIH HHS HL51856NHLBI NIH HHS K08 HL090785NHLBI NIH HHS K24 HL103836NHLBI NIH HHS R01 HL051856NHLBI NIH HHS R37 HL051856
6 · The paper itself

Abstract

The rate of alveolar fluid clearance (AFC) is associated with mortality in clinical acute lung injury (ALI). Patients with ALI often develop circulatory shock, but how shock affects the rate of AFC is unknown. To determine the effect of circulatory shock on the rate of AFC in patients with ALI, the rate of net AFC was measured in 116 patients with ALI by serial sampling of pulmonary edema fluid. The primary outcome was the rate of AFC in patients with shock compared with those without shock. We also tested the effects of shock severity and bacteremia. Patients with ALI and shock (n = 86) had significantly slower rates of net AFC compared with those without shock (n = 30, P = 0.03), and AFC decreased significantly as the number of vasopressors increased. Patients with positive blood cultures (n = 21) had slower AFC compared with patients with negative blood cultures (n = 96, P = 0.023). In addition, the edema fluid-to-plasma protein ratio, an index of alveolar-capillary barrier permeability, was highest in patients requiring the most vasopressors (P < 0.05). Patients with ALI complicated by circulatory shock and bacteremia had slower rates of AFC compared with patients without shock or bacteremia. An impaired capacity to reabsorb alveolar edema fluid may contribute to high mortality among patients with sepsis-induced ALI. These findings also suggest that vasopressor use may be a marker of alveolar-capillary barrier permeability in ALI and provide justification for new therapies that enhance alveolar epithelial and endothelial barrier integrity in ALI, particularly in patients with shock.

Indexed as

Acute Lung InjuryAdultBacteremiaBody FluidsHumansMaleMiddle AgedProspective StudiesPulmonary AlveoliPulmonary EdemaRespiratory Distress SyndromeShockVasoconstrictor AgentsVasoconstrictor Agents

Identifiers

PMID22821995
PMCPMC3468480
OpenAlexW2133650420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.